CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $49.33M, above the global median of $18.73M
- FinancialsAltman Z-Score 3.55: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.80%Above 5Y avg (2.63%)
Annual Rate
CNY 0.40Paid semi-annual
Payout Ratio
39.5%Sustainable
Payback Period
29.6 yr
Last Ex-Dividend
Sep 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.62BCNY689.78M · vs all stocks (USD)
Trailing P/E
13.67xRevenue (TTM)
1.87BCNY279.24M · vs all stocks (USD)
Profit Margin
17.91%Beta
0.2780xvs all stocks
52-Week Change
-8.20%vs all stocks
Forward Annual Dividend Yield
3.80%vs all stocks
Market Capitalization
4.62BCNY689.78M · vs all stocks (USD)
Enterprise Value
4.67BCNY697.69M · vs all stocks (USD)
Trailing P/E
13.67xForward P/E
14.84xPrice to Sales (TTM)
2.44xPrice to Book (MRQ)
2.57xEnterprise to Revenue
2.50xEnterprise to EBITDA
10.95xGross Margin
76.26%Profit Margin
17.91%Operating Margin
21.34%Return on Assets (TTM)
7.13%Return on Equity (TTM)
18.71%Revenue (TTM)
1.87BCNY279.24M · vs all stocks (USD)
Revenue per Share (TTM)
4.25CNYUpdated Sep 22, 2026Quarterly Revenue Growth
18.90%Gross Profit (TTM)
1.39BCNY207.51M · vs all stocks (USD)
EBITDA (TTM)
393.44MCNY58.75M · vs all stocks (USD)
Net Income (TTM)
334.81MCNY50.00M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
34.90%Operating Cash Flow (TTM)
525.01MCNY78.40M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
330.34MCNY49.33M · vs all stocks (USD)
Forward Annual Dividend Rate
0.4000CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
3.80%vs all stocks
Trailing Annual Dividend Rate
0.3500CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
3.32%vs all stocks
5-Year Average Dividend Yield
2.63%vs all stocks
Payout Ratio
39.47%Minority Interest (Equity)
91.15MCNYFY2025 · Dec 31, 2025Revenue
1.75BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
489.54MCNYFY2025 · Dec 31, 2025Gross Profit
1.26BCNYFY2025 · Dec 31, 2025Operating Income
325.70MCNY48.64M · vs all stocks (USD)
Pre-tax Income
353.24MCNYFY2025 · Dec 31, 2025Income Tax Expense
50.61MCNYFY2025 · Dec 31, 2025Net Income
302.64MCNYFY2025 · Dec 31, 2025EBIT
368.05MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
406.70MCNYFY2025 · Dec 31, 2025Research & Development
154.47MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
541.43MCNYFY2025 · Dec 31, 2025Other Operating Expenses
36.61MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.98MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
14.80MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
437.70MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
437.70MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
302.64MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.75MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
289.06MCNYFY2025 · Dec 31, 2025Free Cash Flow
189.16MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
268.17MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
302.64MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.43MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-62.71MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
29.70MCNYFY2025 · Dec 31, 2025Capital Expenditures
-99.90MCNYFY2025 · Dec 31, 2025Net Acquisitions
24.40MCNYFY2025 · Dec 31, 2025Purchase of Investments
-715.00MCNYFY2025 · Dec 31, 2025Sale of Investments
795.43MCNYFY2025 · Dec 31, 2025Other Investing Activity
76.79MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
81.72MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
363.40MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-638.55MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-193.27MCNYFY2025 · Dec 31, 2025Other Financing Charges
-18.68MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-487.10MCNYFY2025 · Dec 31, 2025Shares Outstanding
439.08MSharesUpdated Sep 22, 2026Float Shares
270.90MSharesUpdated Sep 22, 2026% Held by Insiders
38.63%vs all stocks
% Held by Institutions
10.33%vs all stocks
Total Cash (MRQ)
307.67MCNY45.94M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7010CNYUpdated Sep 22, 2026Total Debt (MRQ)
326.80MCNY48.80M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1749xCurrent Ratio (MRQ)
0.9480xBook Value per Share (MRQ)
4.05CNYUpdated Sep 22, 2026Total Assets
3.06BCNY456.32M · vs all stocks (USD)
Total Current Assets
1.01BCNYFY2025 · Dec 31, 2025Total Liabilities
1.25BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.04BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
102.50MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.15BCNYFY2025 · Dec 31, 2025Cash
268.21MCNYFY2025 · Dec 31, 2025Cash Equivalents
8.05MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
276.25MCNYFY2025 · Dec 31, 2025Accounts Receivable
249.03MCNYFY2025 · Dec 31, 2025Inventory
338.71MCNYFY2025 · Dec 31, 2025Accounts Payable
170.62MCNYFY2025 · Dec 31, 2025Short-term Debt
409.32MCNYFY2025 · Dec 31, 2025Other Current Liabilities
8.17MCNYFY2025 · Dec 31, 2025Long-term Debt
22.72MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
3.62MCNYFY2025 · Dec 31, 2025Common Stock (Book)
439.08MCNYFY2025 · Dec 31, 2025Retained Earnings
922.66MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.80BCNY269.22M · vs all stocks (USD)
52-Week Low
8.64CNYUpdated Sep 22, 202652-Week High
13.50CNYUpdated Sep 22, 202652-Week Change
-8.20%vs all stocks
Beta
0.2780xvs all stocks
50-Day MA
10.08CNYUpdated Sep 22, 2026200-Day MA
10.80CNYUpdated Sep 22, 2026Avg 10-Day Volume
7.84MSharesUpdated Sep 22, 2026Avg 30-Day Volume
15.97MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.7600CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.55: safe zoneNotable
Altman Z-Score: 3.55
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $49.33M, above the global median of $18.73MNotable
Levered free cash flow (USD): 49,330,202.62Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Annexon, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Gen Ilac ve Saglik Urunleri A.S.
Tier 1ProductionApproval-Gated PipelineRule
Anhui Huaheng Biotech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineFlow
Revenio Group Oyj
Tier 1ProductionApproval-Gated PipelineRule
Seers Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
ChemPartner Pharmatech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Anglikang Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ironwood Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
MiMedx Group, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Wecome Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking